BARD was founded with aim to research, develop, and produce microbiological products. The products are based on microbiological properties of the microorganism Pythium oligandrum to supress fungal, bacterial, and other ailments in humans and animals.
The company manufactures cosmetics assessed in compliance with Annex I of European Parliament and Council Regulation (EC) No. 1223/2009 for human application. It focuses on a range of products for the care of the human skin, feet, hands, oral cavity, intimate hygiene, and non-healing wounds. The assessment is valid for the European Union. The company is the holder of a decision on the approval of veterinary products, which focus on animals with fungal infections and rotting.